Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving ...

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

President Donald Trump is removing a large portion of HIV funding he previously greenlit for a future without AIDs. For ...

Medical professionals Timothy Holtz and Teri Mills worked with AIDS patients in the 1990s, when treatments were few. With ...

Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...

A landmark breakthrough in HIV prevention — a scientific feat decades in the making — received final approval from the Food ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

Lenacapavir, a long-acting injectable pre-exposure prophylaxis, has been recommended by the WHO to help protect high-risk ...

A breakthrough to reduce risk of HIV in adolescents and adults weighing at least 35 kg. WHO releases the new guidelines ...

Lenacapavir prevents infection and treats HIV, not a 'cure' HIV is the virus that causes AIDS − a disease in which the immune system is damaged to the point that its ability to resist infection ...

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...

How does lenacapavir compare to other HIV prevention drugs? Pre-exposure prophylaxis, or PrEP, medications are sold as a daily pill under brand names Truvada and Descovy, as well as generic versions.